Business Context and Reporting Period
This Form 8-K filing by Anthem, Inc. (now Elevance Health, Inc.) is dated July 24, 2015, reporting on events occurring on July 23, 2015. The primary business event is the announcement of a definitive Agreement and Plan of Merger with Cigna Corporation, under which Anthem will acquire all outstanding shares of Cigna. Additionally, the Board of Directors approved an immediate amendment to the Company's By-Laws designating specific Indiana courts as the exclusive forum for certain legal actions.
Key Financial Metrics
The filing provides specific earnings data for the second quarter of 2015 and updated guidance for the full year 2015. Detailed revenue, cash flow, debt, and liquidity figures are not provided in this specific filing; investors are directed to the quarterly earnings conference call for further details.
- Q2 2015 Net Income: $3.13 per share (includes $0.03 per share in net gains).
- Q2 2015 Adjusted Net Income: $3.10 per share (excludes net gains).
- Full Year 2015 Net Income Guidance: Greater than $9.75 per share.
- Full Year 2015 Adjusted Net Income Guidance: Greater than $10.00 per share.
- Full Year 2015 Net Adjustment Items: Greater than $0.25 per share (unfavorable).
| Adjustment Item | Impact on EPS |
|---|---|
| Net realized gains on investments | ($0.33) |
| Other-than-temporary impairment losses on investments | $0.08 |
| Loss on extinguishment of debt | $0.00 |
| Amortization of other intangible assets | Greater than $0.50 |
Material Changes
The most significant material change is the initiation of the acquisition of Cigna Corporation. This represents a major strategic shift and potential consolidation in the health insurance sector. The filing also notes a change in corporate governance via the By-Law Amendment regarding legal forums. Financially, the company has updated its full-year outlook to reflect specific adjustment items, including investment gains and intangible asset amortization, which were not detailed in prior comparable periods with this level of granularity in this specific document.
Guidance, Outlook, and Risks
Guidance and Outlook: Management expects full-year 2015 adjusted net income to exceed $10.00 per share. This guidance explicitly excludes future merger-related transaction costs. The company plans to provide further financial details during a conference call on July 29, 2015.
Risks and Contingencies: The filing includes an extensive Safe Harbor statement regarding forward-looking information. Key risks identified include:
- Regulatory approvals required for the Cigna merger.
- Shareholder approval requirements for both companies.
- Integration risks and potential disruption to operations.
- Healthcare reform impacts (Affordable Care Act) on premium rates and enrollment.
- Cybersecurity risks, specifically referencing a cyber attack reported in February 2015.
- General economic downturns and changes in investment portfolio liquidity.
Investor Verification Checklist
- Verify the terms of the Merger Agreement with Cigna in the separate Form 8-K filing referenced in Item 8.01.
- Review the joint proxy statement/prospectus (Form S-4) for detailed transaction terms and voting procedures.
- Confirm the status of regulatory approvals required to close the Cigna acquisition.
- Attend or review the transcript of the July 29, 2015, earnings conference call for full revenue and cash flow details.
- Assess the impact of the By-Law Amendment on shareholder litigation rights.